This is a snippet of the transcript, sign up to read more.
Yes, a lot of things. Historically, all these partners that Dynatrace works with now are very old partners. Let's go back to when Dynatrace was not the current Dynatrace but the older solution, like AppMon and DC RUM, and network monitoring, and Keynote. These partners would do a lot of other stuff. They were Cisco partners, they deployed networks, they had Symantec, they had Microsoft products, and they had a very strong relationship with the customers. Not only that, in ASEAN or in Asia, including Taiwan and other regions like Korea and Japan, they understood how procurement works. They had a very strong relationship at the backend, which these partners brought to the table, which helped Dynatrace to close and expedite the deals.
This is a snippet of the transcript, sign up to read more.
Let me give you an example. Three years ago, just before Covid, for the Account Executive, the quota retirement was based on TCV, Total Contract Value. If a total contract value is, say, 1.5 or three million, depending on the quota, then you qualify and that's your number, and you get compensated accordingly. Now, some of the deals, especially when you're working with banks, telcos, or the government, the average sales cycles in the region are a minimum of nine months, typically ranging from six to nine months. When you have a lot of things in the pipeline because of the past budget and you've put in the year before, changing the plan all of a sudden on April 1 impacts everyone. That was one issue. Then you change your mindset, and then you change again and say, "Okay, let's start now and then next year we will build on that." Even if I lose my quota, even if I miss my number this year, I'll build up on it for next year. And then the following year, they switch back to ACV from TCV. This has happened quite often, leading to inconsistency for the salespeople as well.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.